Literature DB >> 2921366

Sensitivity of Campylobacter pylori to colloidal bismuth subcitrate.

C S Goodwin, B Bell, C McCullough, M Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2921366      PMCID: PMC1141833          DOI: 10.1136/jcp.42.2.216-b

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

Review 1.  Fine needle aspiration cytology.

Authors:  J V Lever; P A Trott; A J Webb
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

2.  Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.

Authors:  C A McNulty; J Dent; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

3.  Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents.

Authors:  T Lambert; F Mégraud; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

4.  Treatment failure of ofloxacin in Campylobacter pylori infection.

Authors:  Y Glupczynski; M Labbe; A Burette; M Delmee; V Avesani; C Bruck
Journal:  Lancet       Date:  1987-05-09       Impact factor: 79.321

5.  Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Authors:  C S Goodwin; B J Marshall; E D Blincow; D H Wilson; S Blackbourn; M Phillips
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

6.  The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

Authors:  C S Goodwin; P Blake; E Blincow
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

7.  Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

Authors:  J G Coghlan; D Gilligan; H Humphries; D McKenna; C Dooley; E Sweeney; C Keane; C O'Morain
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.